Dr Adam Edwards is the lead of Discovery and Translational Sciences within the Perron Institute Stroke Research Centre, adjunct Senior Postdoctoral Research Fellow at the University of Western Australia and the Neonatal Scientific and Regulatory Affairs Advisor at Argenica Therapeutics. In addition to his Australian domestic appointments, Dr Edwards is a visiting Senior Postdoctoral Research Fellow at Aarhus University and Aarhus University Hospital in Denmark. Dr Edwards completed his PhD under Professor Bruno Meloni and Professor Neville Knuckey at the Perron Institute for Neurological and Translational Science in 2019. Dr Edwards’ research passion is to improve the lives of individuals with stroke, with a particular focus on infants born with brain injury. Dr Edwards’ research includes the development of novel drug therapies and diagnostics to reduce the burden of stroke (neonatal and adult).

Since 2019, Dr Edwards has received $8 million in competitive grant funding and has authored 16 publications with 494 citations (h index = 10) and is a specialist editor in Stroke for Frontiers in Neurology. Dr Edwards has a key focus on translating therapies and diagnostics from ‘bench to bedside’ and has authored 3 ASX announcements relating to preclinical research outputs and has been awarded 1 Breakthrough Device Designation (FDA), 2 Orphan Drug Designations (FDA) and 2 Rare Pediatric Disease Designations (FDA). In addition, Dr Edwards is an inaugural member of the Critical Path Institute’s International Neonatal Consortium to accelerate drug development for neonates; he Critical Path Institute is the FDA’s national strategy for transforming the way FDA-regulated products are developed, evaluated and manufactured.

In 2024 Dr Edwards was shortlisted for Western Australian of the Year (Youth category) and a finalist for the Prime Minister’s Award for Science (New Innovator Category). Dr Edwards finds himself fortunate to be mentored by highly motivated, passionate and dedicated researchers and wants to extend the same support to prospective students and early career researchers in an attempt to improve the lives of some of the most vulnerable individuals within our society.

View Publications    Email